Synthetic Genomics, Inc. To Present At The J.P. Morgan 34th Annual Healthcare Conference

LA JOLLA, Calif., Jan. 6, 2016 /PRNewswire/ -- Synthetic Genomics, Inc. (SGI) announced today that Oliver Fetzer, Ph.D., MBA, chief executive officer of Synthetic Genomics, Inc., will provide a corporate overview and presentation at the J.P. Morgan 34th Annual Healthcare Conference on Wednesday, January 13, 2016 at 1:00 p.m. ET (10:00 a.m. PT) in San Francisco, California.

About Synthetic Genomics

SGI is a privately-held company dedicated to developing and commercializing genomic-driven solutions to address a wide range of global challenges. We are using this technology, and developing new and more advanced methods, to create the next generation of renewable and sustainably-produced biology-based products.The company is focused on several key commercialization programs including developing new synthetic DNA products, tools and instruments; improving existing production hosts and developing new synthetic hosts; developing new and improved algae-based biofuels, food and nutritional products; and developing synthetically-derived vaccines and anti-microbials. The company is also developing sustainable agricultural products through AgraCast, a company co-founded with Plenus S.A. de C.V.  For more information go to:

Company Contact:
Ben Chiarelli, VP of Corporate Development and Strategy 

Media Contact:
Jason I. Spark, Senior Vice President
Canale Communications 


To view the original version on PR Newswire, visit:

SOURCE Synthetic Genomics, Inc.

Back to news